Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection.

Chen-Hua LiuH-Y SunChun-Jen LiuW-H ShengS-M HsiehY-C LoW-C LiuT-H SuH-C YangC-M HongT-C TsengP-J ChenD-S ChenChien-Ching Hung Jia-Horng Kao

Published in: Alimentary pharmacology & therapeutics (2018)

Generic VEL/SOF-based therapy is well-tolerated and provides comparably high SVR12 rates for HCV infection in patients with and without HIV coinfection.

Keyphrases

human immunodeficiency virus
hepatitis c virus infection
hepatitis c virus
antiretroviral therapy
hiv infected
hiv positive
hiv aids
hiv testing
stem cells